Ischemia Clinical Trial
Official title:
Evaluation of Clinical Outcome in Advanced Chronic Lower Limb Ischemia by Stem Cell Transplantation With or Without (Granulocyte-colony Stimulation Factor) G-CSF Injection
Verified date | April 2010 |
Source | Royan Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | Iran: Ministry of Health |
Study type | Interventional |
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of mononuclear cells with and without G-CSF in patients with chronic lower limb ischemia.
Status | Completed |
Enrollment | 20 |
Est. completion date | January 2010 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Presence of Critical Limb ischemia according to the guidelines of the Transatlantic Consensus Group (TASC) Rutherford grade II or III. Perfusion is measured with absolute perfusion pressure and ankle-brachial index (ABI) and transcutaneous oxygen tension (TcpO2); for inclusion, ABI has to be less than or equal to 0.6 or absolute ankle pressure must be less than 60 mmHg. If ABI is technically not feasible, e.g. in patients with media calcification, inclusion criteria are a tcpO2 value (supine, forefoot, 44°C) of less than 20 mmHg if there is no tissue loss, or a tcpO2 of less than 40 mmHg if there is tissue loss. - No sufficient response to best standard care delivered for six weeks. - No surgical or radiological interventional option for revascularisation as confirmed by a vascular surgeon and an interventional radiologist - Signed informed consent - Absence of life-threatening complications from the ischemic limb Exclusion Criteria: - Expected life span less than six months - Bone marrow diseases which preclude transplantation (eg lymphoma, leukaemia, myelodysplastic syndrome and others) - Patients with poorly controlled diabetes mellitus (HbA1C > 8%) - Patients with renal insufficiency (creatinine > 2.5). - Patients with evidence of infectious disease as determined by e. above or other medical findings. - Pregnant women (women capable of childbearing must have a negative pregnancy test). - Patients with cognitive impairments. - Other comorbid disease that would be expected to result in less than one year life expectancy - Past malignancy or history of chemotherapy or radiation affecting the bone marrow. - History of inflammatory or progressively fibrotic conditions: .e.g., rheumatoid arthritis, systemic lupus erythematosis, vasculitic disorders, idiopathic pulmonary fibrosis, retroperitoneal fibrosis - Infection as evidenced by WBC count of >15,000 and/or temperature more than 38C. Large area of cellulitis in the afflicted limb that in the opinion ofthe investigators would require the institution of antibiotics OR evidence of osteomyelitis corroborated by radiographic or scintigraphic examination - Cardiovascular conditions: - EF<30% - Acute ST elevation myocardial infarction (MI) within 1month; - Transient ischemic attack or stroke within 1 month; - Severe valvular disease - CVA - Patients with any history of organ transplants |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Royan Institute | Tehran | |
Iran, Islamic Republic of | Tehran University of medical sciences, Vascular Surgery department, Sina Hospital | Tehran |
Lead Sponsor | Collaborator |
---|---|
Royan Institute | Tehran University of Medical Sciences |
Iran, Islamic Republic of,
Zafarghandi MR, Ravari H, Aghdami N, Namiri M, Moazzami K, Taghiabadi E, Fazel A, Pournasr B, Farrokhi A, Sharifian RA, Salimi J, Moini M, Baharvand H. Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intram — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Major amputation | six months | Yes | |
Secondary | Minor amputation | six months | Yes | |
Secondary | Number and extent of leg ulcers | six months | No | |
Secondary | Resolvement of rest pain | six months | No | |
Secondary | Improvement of ankle-brachial index (ABI) | six months | No | |
Secondary | Improvement of pain free walking distances ( PFWD) | six months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05443061 -
Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
|
N/A | |
Recruiting |
NCT05158257 -
Clinical Of Plain Balloon Dilatation Combined Stent Versus Endovascular Debulking Combined Drug-coated Balloon to Treat Arteriosclerosis Occlusive Disease of Lower Extremity
|
N/A | |
Recruiting |
NCT06006975 -
Early Warning of Delayed Cerebral Ischemia
|
||
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Completed |
NCT02758847 -
Evaluation of Paclitaxel in Patients With CLI and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty
|
N/A | |
Completed |
NCT02557282 -
CARESTREAM Vue PACS v12.1.5 CT Perfusion Clinical Protocol
|
||
Enrolling by invitation |
NCT02033681 -
Optimal Time Delay of Epinephrine Injection With "One-per-mil" Tumescent Solution
|
N/A | |
Completed |
NCT01608035 -
Sciatic Perineural Versus Stump Catheter for Below Knee Amputation
|
Phase 0 | |
Active, not recruiting |
NCT01518842 -
Effect of Intravitreal Bone Marrow Stem Cells on Ischemic Retinopathy
|
N/A | |
Completed |
NCT01625832 -
Effects of Coronary Sinus Occlusion on Myocardial Ischemia (Pilot Study)
|
N/A | |
Active, not recruiting |
NCT01281241 -
Study on Mechanical and Electrical Alternans
|
N/A | |
Completed |
NCT00778323 -
Clinical Trial of Remote Preconditioning in Patients Undergoing Cervical Decompression Surgery
|
Phase 1/Phase 2 | |
Completed |
NCT00371371 -
Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)
|
Phase 1/Phase 2 | |
Terminated |
NCT00760708 -
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
|
||
Not yet recruiting |
NCT06039748 -
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
|
||
Completed |
NCT04879875 -
New Method for Real-time Detection of Tissue Ischemia (ISCALERT)
|
N/A | |
Completed |
NCT00526474 -
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
|
Phase 3 | |
Completed |
NCT03994822 -
pRESET for Occlusive Stroke Treatment
|
N/A | |
Completed |
NCT02910778 -
The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
|
Phase 4 | |
Completed |
NCT02703142 -
Endoscopic Evaluation After Esophagectomy
|
N/A |